US2021238559A1PendingUtilityA1
Methods and Systems for Rapid Detection of Microorganisms Using Infectious Agents
Assignee: LABORATORY CORP AMERICA HOLDINGSPriority: Feb 21, 2013Filed: Feb 8, 2021Published: Aug 5, 2021
Est. expiryFeb 21, 2033(~6.6 yrs left)· nominal 20-yr term from priority
C12Q 1/10C12Q 1/6804C12Q 2600/158C12N 2795/00021C12Q 1/689C12N 2795/00052C12N 7/00
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed herein are methods and systems for rapid detection of microorganisms in a sample. A genetically modified bacteriophage is also disclosed which comprises an indicator gene in the late gene region. The specificity of the bacteriophage, such as CBA120, allows detection of a specific microorganism, such as E. coli O157:H7, and an indicator signal may be amplified to optimize assay sensitivity.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A recombinant bacteriophage comprising an indicator gene inserted into a late gene region of the bacteriophage CBA120 genome.
2 . The recombinant bacteriophage of claim 1 , wherein the recombinant bacteriophage specifically infects E. coli O157:H7.
3 . The recombinant bacteriophage of claim 1 , wherein the indicator gene is codon-optimized and encodes a soluble protein product that generates an intrinsic signal or a soluble enzyme that generates signal upon reaction with substrate.
4 . The recombinant bacteriophage of claim 3 , further comprising an untranslated region upstream of the codon-optimized indicator gene, wherein the untranslated region includes a bacteriophage late gene promoter and a ribosomal entry site.
5 . A method of preparing a recombinant indicator bacteriophage comprising:
selecting a wild-type bacteriophage that specifically infects a target pathogenic bacterium; preparing a homologous recombination plasmid/vector comprising an indicator gene; transforming the homologous recombination plasmid/vector into target pathogenic bacteria; infecting the transformed target pathogenic bacteria with the selected wild-type bacteriophage, thereby allowing homologous recombination to occur between the plasmid/vector and the bacteriophage genome; and isolating a particular clone of recombinant bacteriophage.
6 . The method of claim 5 , wherein preparing a homologous recombination plasmid/vector comprises:
determining the natural nucleotide sequence in the late region of the genome of the selected bacteriophage; annotating the genome and identifying the major capsid protein gene of the selected bacteriophage; designing a sequence for homologous recombination downstream of the major capsid protein gene, wherein the sequence comprises a codon-optimized indicator gene; and incorporating the sequence designed for homologous recombination into a plasmid/vector.
7 . The method of claim 6 , wherein designing a sequence further comprises inserting an untranslated region including a phage late gene promoter and ribosomal entry site upstream of the codon-optimized indicator gene.
8 . The method of claim 5 , wherein the homologous recombination plasmid comprises an untranslated region including a bacteriophage late gene promoter and a ribosomal entry site upstream of the codon-optimized indicator gene.
9 . The method of claim 5 , wherein the wild-type bacteriophage is CBA120 and the target pathogenic bacterium is E. coli O157:H7.
10 . The method of claim 5 , wherein isolating a particular clone of recombinant bacteriophage comprises a limiting dilution assay for isolating a clone that demonstrates expression of the indicator gene.
11 . A method for detecting E. coli O157:H7 in a sample comprising:
incubating the sample with a recombinant bacteriophage derived from CBA120, and detecting an indicator protein product produced by the recombinant bacteriophage, wherein positive detection of the indicator protein product indicates that E. coli O157:H7 is present in the sample.
12 . The method of claim 11 , wherein the sample is a food, environmental, water, commercial, or clinical sample.
13 . The method of claim 11 , wherein the method detects as few as 10, 9, 8, 7, 6, 5, 4, 3, 2, or a single bacterium in a sample of a standard size for the food safety industry.
14 . The method of claim 12 , wherein the sample comprises beef or vegetables.
15 . The method of claim 11 , wherein the sample is first incubated in conditions favoring growth for an enrichment period of 9 hours or less, 8 hours or less, 7 hours or less, 6 hours or less, 5 hours or less, 4 hours or less, 3 hours or less, or 2 hours or less.
16 . The method of claim 11 , wherein the total time to results is less than 12 hours, less than 11 hours, less than 10 hours, less than 9 hours, less than 8 hours, less than 7 hours, or less than 6 hours.
17 . The method of claim 11 , wherein the ratio of signal to background generated by detecting the indicator is at least 2.0 or at least 2.5.
18 . A kit for detecting E. coli O157:H7 comprising a recombinant bacteriophage derived from CBA120.
19 . The kit of claim 18 , further comprising a substrate for reacting with an indicator to detect the soluble protein product expressed by the recombinant bacteriophage.
20 . A system for detecting E. coli O157:H7 comprising a recombinant bacteriophage derived from CBA120.Join the waitlist — get patent alerts
Track US2021238559A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.